Clinical Trial Update: Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

View source ↗

Summary

Completed clinical trial evaluating Optina Diagnostics' Cerebral β-Amyloid Status (CAS) test for determining cerebral amyloid status in Alzheimer's disease and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia

Snippet

Sponsor: Optina Diagnostics Inc. | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Status: COMPLETED